Wilson, LA
Brett A. Wilson, Lafayette, LA US
Patent application number | Description | Published |
---|---|---|
20080210421 | Tagged Propping Agents and Related Methods - A proppant composition comprises a non-radioactive, detectable tracer at least partially embedded in a ceramic composition. The composition may be prepared by agglomerating granules of the ceramic material and granules of the non-radioactive, detectable material to produce the particle by compression. Backflow of proppants in a fractured subterranean formation into which a plurality of particles of the proppant composition have been introducted may be tracked by analyzing a sample of the backflow by detecting for presence of the tracer in the sample. | 09-04-2008 |
20110177984 | Tagged Propping Agents and Related Methods - A proppant particle comprising a sintered proppant composition that comprises a non-radioactive, detectable tracer uniformly distributed throughout a ceramic composition, wherein the tracer is one or more tracer metal oxides and the tracer metals are selected from a group consisting of lanthanides, strontium, barium, gallium, germanium, tantalum, vanadium, and manganese. | 07-21-2011 |
Brett Allen Wilson, Lafayette, LA US
Patent application number | Description | Published |
---|---|---|
20080220996 | SINTERED SPHERICAL PELLETS - Sintered, spherical composite pellets or particles comprising alumina fines, at least one of clay and bauxite and optionally a sintering aid, are described, along with a process for their manufacture. The use of such pellets in hydraulic fracturing of subterranean formations and in grinding is also described. | 09-11-2008 |
20090118145 | METHOD FOR PRODUCING PROPPANT USING A DOPANT - A method for producing sintered pellets and sintered pellets produced therefrom including mixing a dopant with water and kaolin clay to form substantially round and spherical green pellets and sintering the pellets to form a proppant. The dopant is selected from the group consisting of potassium carbonate, potassium sulfate, potassium chloride, mica, kalsilite, and combinations thereof. | 05-07-2009 |
20100059224 | METHODS FOR PRODUCING SINTERED PARTICLES FROM A SLURRY OF AN ALUMINA-CONTAINING RAW MATERIAL - Methods for producing substantially round, spherical and sintered particles from a slurry of a calcined, uncalcined or partially calcined raw material having an alumina content of more than 55% by weight, and a mullite growth promoter in an amount of from about 2 to about 10% dry weight of the total solids in the slurry. Methods for using such substantially round, spherical and sintered particles in hydraulic fracturing operations. | 03-11-2010 |
20100126728 | SINTERED SPHERICAL PELLETS - Sintered, spherical composite pellets or particles comprising alumina fines, at least one of clay and bauxite and optionally a sintering aid, are described, along with a process for their manufacture. The use of such pellets in hydraulic fracturing of subterranean formations and in grinding is also described. | 05-27-2010 |
Bruce Mackie Wilson, Metairie, LA US
Patent application number | Description | Published |
---|---|---|
20120035788 | NAVIGATION AND CONTROL SYSTEM FOR AUTONOMOUS VEHICLES - A navigation and control system including a sensor configured to locate objects in a predetermined field of view from a vehicle. The sensor has an emitter configured to repeatedly scan a beam into a two-dimensional sector of a plane defined with respect to a first predetermined axis of the vehicle, and a detector configured to detect a reflection of the emitted beam from one of the objects. The sensor includes a panning mechanism configured to pan the plane in which the beam is scanned about a second predetermined axis to produce a three dimensional field of view. The navigation and control system includes a processor configured to determine the existence and location of the objects in the three dimensional field of view based on a position of the vehicle and a time between an emittance of the beam and a reception of the reflection of the emitted beam from one of the objects. | 02-09-2012 |
20130131908 | NAVIGATION AND CONTROL SYSTEM FOR AUTONOMOUS VEHICLES - A navigation and control system including a sensor configured to locate objects in a predetermined field of view from a vehicle. The sensor has an emitter configured to repeatedly scan a beam into a two-dimensional sector of a plane defined with respect to a first predetermined axis of the vehicle, and a detector configured to detect a reflection of the emitted beam from one of the objects. The sensor includes a panning mechanism configured to pan the plane in which the beam is scanned about a second predetermined axis to produce a three dimensional field of view. The navigation and control system includes a processor configured to determine the existence and location of the objects in the three dimensional field of view based on a position of the vehicle and a time between an emittance of the beam and a reception of the reflection of the emitted beam from one of the objects. | 05-23-2013 |
Chester Wilson, Ruston, LA US
Patent application number | Description | Published |
---|---|---|
20150071843 | Nanofilaments of Catalytic Materials for Chemical Process Improvements - A Haber-Bosch process including the steps of providing a reactor having a substrate with catalyst filaments formed thereon. The catalyst filaments are formed of a metal including iron. A nitrogen compound and hydrogen are injected into the reactor such that at least a portion of the nitrogen compound and hydrogen contact the catalyst filaments. The nitrogen compound and hydrogen are reacted with the catalyst filaments at a temperature of less than about 600° F. and a pressure of less than about 2000 psig. | 03-12-2015 |
Dean Randal Wilson, Marrero, LA US
Patent application number | Description | Published |
---|---|---|
20090149089 | Deep water amphibious vehicle - A vehicle is adapted to operate on land and in water having a depth of over four feet. The vehicle includes a chassis, one or more pontoons supported by the chassis, and a track system disposed on each of the one or more pontoons and adapted to provide propulsion to the vehicle. Each pontoon has a height of at least four feet, a width and a length adjacent to the land, wherein a ratio of the height to the width exceeds 1.4, and a volume configured to provide buoyancy and support the chassis weight. | 06-11-2009 |
Martez Wilson, Metairie, LA US
Patent application number | Description | Published |
---|---|---|
20130221652 | Imprinted Tape for Combined Functional and Decorative Purposes - In order to spat an athletic performer's shoes to reinforce the foot and the ankle, an elongated tape formed of a flexible base Is coated on one side with a pressure-sensitive adhesive and imprinted on the other side with repetitive versions of a team or sponsor's trademark, logo,, or the like in colors associated with the team, or sponsor. The tape may be used by wrapping the shoes and ankles in a manner known as spatting to reinforce the shoes and display the imprinted design, | 08-29-2013 |
20140230164 | IMPRINTED TAPE FOR COMBINED FUNCTIONAL AND DECORATIVE PURPOSES - In order to spat an athletic performer's shoes to reinforce the foot and the ankle, an elongated tape formed of a flexible base is coated on one side with a pressure-sensitive adhesive and imprinted on the other side with repetitive versions of a team or sponsor's trademark, logo, or the like in colors associated with the team or sponsor. The tape may be used by wrapping the shoes and ankles in a manner known as spatting to reinforce the shoes and display the imprinted design. | 08-21-2014 |
Russell Wilson, Mandeville, LA US
Patent application number | Description | Published |
---|---|---|
20090264362 | Influenza virus inhibiting peptides - The present invention provides a pharmaceutical composition for the treatment or prevention of an influenza infection. The composition comprises an isolated polypeptide including a sequence of at least 8 contiguous amino acid residues of the fusion initiation region (FIR) of an influenza hemagglutinin 2 protein or a peptide analog of the sequence. The FIR is a segment of the full length hemagglutinin 2 protein which is bounded by an amino-terminal region within the amino-terminal alpha-helix thereof and a carboxy terminus within the carboxy-terminal alpha-helix thereof, with a cysteine loop therebetween. The amino-terminal region of the FIR comprises a portion of the final 10 to 20 amino acid residues of the amino-terminal alpha-helix of the hemagglutinin 2 protein, and includes 3 or 4 hydrophobic amino acid residues, a positively-charged amino acid residue, a negatively-charged amino acid residue, and an aromatic amino acid residue. The carboxy terminus of the FIR is the carboxy terminus of the first peptide sequence of the hemagglutinin 2 protein beyond the amino terminal helix, which exhibits a positive Wimley-White interfacial hydrophobicity. | 10-22-2009 |
20120289458 | TREATMENT OF INFLUENZA VIRUS INFECTION - The present invention provides method for the treatment of an ongoing influenza infection by administering a polypeptide to a subject suffering from an influenza infection. The polypeptide consists of the fusion initiation region (FIR) of an influenza hemagglutinin 2 protein or an 8 to 40 amino acid residue portion thereof. In one embodiment, the polypeptide consists of SEQ ID NO: 4 or an 8 to 40 contiguous amino acid residue portion thereof. The present invention also provides a method of interfering with fusion of an influenza virus envelope with a host cell membrane by contacting the host cell with the FIR polypeptide. | 11-15-2012 |
Russell B. Wilson, Mandeville, LA US
Patent application number | Description | Published |
---|---|---|
20100152109 | Influenza inhibiting compositions and methods - The present invention provides peptides, peptide analogs, peptide derivatives and pharmaceutical compositions useful for treating or preventing influenza infections or preventing the person-to-person transmission of an influenza infection. A peptide of the invention comprises an influenza virus-cell fusion inhibiting portion of the fusion initiation region (FIR) of a wild-type influenza hemagglutinin 2 protein or a variant thereof. In a preferred embodiment, a peptide of the invention consists of 8 to 40 consecutive amino acid residues a portion of a wild-type influenza hemagglutinin 2 protein or a variant thereof, the portion of the protein comprising the FIR of the protein and up to five amino acid residues on the amino-terminal and carboxy-terminal sides of the FIR. | 06-17-2010 |
20100261640 | SOLUBLE AND MEMBRANE ANCHORED FORMS OF LASSA VIRUS SUBUNIT PROTEINS - The invention discloses compositions comprising soluble and membrane-anchored forms of Lassa virus (LASV) glycoprotein 1 (GP1), glycoprotein 2 (GP2), the glycoprotein precursor (GPC), the nucleocapsid protein (NP), and the nucleic acids encoding these proteins. This invention further relates to diagnostic and preventative methods using these compositions. Preventative methods include preparation of vaccines, as well as factors (e.g. small molecules) that inhibit LASV infectivity. Further, the invention relates to diagnostic and therapeutic antibodies including neutralizing antibodies for the prevention and treatment of infection by LASV and other arenaviruses. | 10-14-2010 |
20140194347 | INFLUENZA INHIBITING COMPOSITIONS AND METHODS - The present invention provides peptides, peptide analogs, peptide derivatives and pharmaceutical compositions useful for treating or preventing influenza infections or preventing the person-to-person transmission of an influenza infection. A peptide of the invention comprises an influenza virus-cell fusion inhibiting portion of the fusion initiation region (FIR) of a wild-type influenza hemagglutinin 2 protein or a variant thereof. In a preferred embodiment, a peptide of the invention consists of 8 to 40 consecutive amino acid residues a portion of a wild-type influenza hemagglutinin 2 protein or a variant thereof, the portion of the protein comprising the FIR of the protein and up to five amino acid residues on the amino-terminal and carboxy-terminal sides of the FIR. | 07-10-2014 |
20140271580 | IMMUNOPROTECTIVE PRIMARY MESENCHYMAL STEM CELLS AND METHODS - Immunoprotective primary mesenchymal stems cells (IP-MSC) which episomally express multiple immunoreactive polypeptides that specifically target a pathogen (e.g., an infectious species of virus, bacterium, or parasite) or toxin are described herein. The IP-MSC express two or more (e.g., 2 to about 100) immunoreactive polypeptides (e.g., full antibodies, single-chain antibodies (ScFV), Fab or F(ab) | 09-18-2014 |
20140271650 | IMMUNOGENIC PEPTIDE CONJUGATE AND METHOD FOR INDUCING AN ANTI-INFLUENZA THERAPEUTIC ANTIBODY RESPONSE THEREWITH - Immunogenic influenza hemagglutinin-derived peptide conjugates described herein induce a specific therapeutic antibody response against influenza virus. The immunogenic peptide conjugates comprise a segment from the fusion initiation region (FIR) domain of an influenza hemagglutinin protein conjugated to an immunogenic carrier protein, such as keyhole limpet hemocyanin (KLH), bovine serum albumin (BSA), an influenza hemagglutinin (HA) protein (i.e., full length HA), and the like. The immunogenic peptide conjugates described herein can be utilized to treat or prevent influenza infection and to prepare influenza-specific therapeutic antibodies that interfere with influenza virus-host cell membrane fusion. The peptide conjugates can be formulated in pharmaceutical compositions useful for broad spectrum treatment or prevention of influenza infections. | 09-18-2014 |
20140377740 | SOLUBLE AND MEMBRANE-ANCHORED FORMS OF LASSA VIRUS SUBUNIT PROTEINS - Soluble and membrane-anchored forms of Lassa virus (LASV) glycoprotein 1 (GP1), glycoprotein 2 (GP2), the glycoprotein precursor (GPC), the nucleocapsid protein (NP), and the nucleic acids encoding these proteins are disclosed, as well as diagnostic and preventative methods using these compositions. Also disclosed are methods including preparation of vaccines, factors (e.g. small molecules) that inhibit LASV infectivity, and diagnostic and therapeutic antibodies including neutralizing antibodies for the prevention and treatment of infection by LASV and other arenaviruses. | 12-25-2014 |
William Joseph Wilson, Laplace, LA US
Patent application number | Description | Published |
---|---|---|
20080304938 | Strongback Traveling Clamp - A modified strongback for laying pipeline offshore that utilizes a movable clamp. One end of the strongback is modified to include a travel mechanism. A pipe clamp is mounted on the travel mechanism to allow movement of the clamp as necessary to accommodate different pipe joint lengths. A mechanism for locking the clamp in the desired position is provided on the strongback. | 12-11-2008 |